ADVANCING FOCUSED ULTRASOUND IN SOUTH AFRICA
HIFUNSA is a South African focused-ultrasound platform centred on the introduction, education and responsible clinical application of advanced HIFU technology. Our focus is on bringing internationally developed focused ultrasound technology into a South African context through evidence, education, technology and appropriate clinical application.
A SOUTH AFRICAN FOCUSED ULTRASOUND INITIATIVE
HIFUNSA exists to create a dedicated platform for High-Intensity Focused Ultrasound (HIFU) technology in South Africa. The platform is centred around the JC300, a focused ultrasound therapeutic system developed by Chongqing Haifu Medical Technology Co., Ltd. Our approach brings together: - Technology - - Clinical application - - Evidence - - Patient education - - Professional education - - Research - The objective is not simply to introduce a machine, but to build an informed ecosystem around the technology.
WHY HIFUNSA EXISTS
Focused ultrasound represents a different approach to delivering a therapeutic effect: using concentrated acoustic energy to target tissue without requiring conventional surgical access to the target. HIFUNSA's purpose is to help make this technology understandable, accessible and responsibly implemented within the South African healthcare environment. OUR PURPOSE To advance understanding and responsible application of focused ultrasound technology in South Africa.
THE JC300
At the centre of HIFUNSA is the JC300 Focused Ultrasound Tumor Therapeutic System. The system belongs to Haifu's established family of focused ultrasound therapeutic technologies. The JC300 combines: - Therapeutic ultrasound - - Imaging - - Target localisation - - Treatment planning - - Controlled energy delivery - - Treatment monitoring - The result is a technology platform designed around the principle of delivering focused ultrasound energy to a defined target region.
BRINGING GLOBAL TECHNOLOGY INTO A SOUTH AFRICAN CONTEXT
HIFU is an established area of medical technology with decades of development and international clinical experience. Haifu reports that its HIFU systems have been deployed across 36 countries and regions, with more than 360,000 patients treated worldwide and more than 3,000 physicians trained. These are manufacturer-reported figures covering the broader Haifu HIFU technology portfolio, not JC300 alone. South Africa also has a documented history with Haifu technology, including the introduction of a JC200 system at Chris Hani Baragwanath Hospital in 2015, reported by Haifu as the first such system in Africa. HIFUNSA represents the next stage of this technology story: From international HIFU development → to African clinical experience → to the next generation of focused ultrasound technology in South Africa.
TECHNOLOGY WITHOUT THE HYPE
HIFUNSA believes that advanced medical technology should be presented with clarity, evidence and transparency. We therefore distinguish between: WHAT THE TECHNOLOGY DOES The engineering and physical principles behind focused ultrasound. WHAT THE EVIDENCE SHOWS Peer-reviewed clinical research and published outcomes. WHAT THE MANUFACTURER REPORTS Deployment, technology history and manufacturer-reported experience. WHAT IS CLINICALLY APPROPRIATE Individual treatment decisions made through appropriate clinical assessment.
BUILT AROUND EVIDENCE
HIFUNSA's information architecture should allow visitors to move from simple patient education into increasingly technical information. PATIENT INFORMATION Understanding fibroids and HIFU. ↓ JC300 TECHNOLOGY Understanding the machine. ↓ CLINICAL EVIDENCE Understanding published research. ↓ CASE EXPERIENCE Understanding documented clinical experience. ↓ RESEARCH & EDUCATION Understanding the broader development of focused ultrasound.
EDUCATION IS PART OF THE TECHNOLOGY
HIFUNSA should operate as an educational resource—not simply a treatment destination. We explain: - What HIFU is - - How focused ultrasound works - - How JC300 works - - Who may be suitable - - What the evidence says - - What the limitations are - - What alternative treatments exist - - What questions patients should ask-
OUR VALUES
PRECISION Technology should be understood through accurate information. EVIDENCE Clinical claims should be supported by appropriate evidence. TRANSPARENCY Limitations and alternatives should be communicated openly. INNOVATION We remain engaged with developments in focused ultrasound technology. ACCESS Advanced technology should become increasingly understandable and accessible within the appropriate healthcare environment. RESPONSIBILITY Technology must operate within appropriate clinical, ethical and regulatory frameworks.